{"id":"https://openalex.org/W2064423675","doi":"https://doi.org/10.1097/00007691-199103000-00013","title":"Intraindividual Variability of Carbamazepine, Phenobarbital, and Phenytoin Concentrations in Saliva","display_name":"Intraindividual Variability of Carbamazepine, Phenobarbital, and Phenytoin Concentrations in Saliva","publication_year":1991,"publication_date":"1991-03-01","ids":{"openalex":"https://openalex.org/W2064423675","doi":"https://doi.org/10.1097/00007691-199103000-00013","mag":"2064423675","pmid":"https://pubmed.ncbi.nlm.nih.gov/2053125"},"language":"en","primary_location":{"id":"doi:10.1097/00007691-199103000-00013","doi":"https://doi.org/10.1097/00007691-199103000-00013","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-199103000-00013","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019341812","display_name":"Michael V. Miles","orcid":"https://orcid.org/0000-0002-6624-330X","observed_orcids":["https://orcid.org/0000-0002-6624-330X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael V. Miles","raw_affiliation_strings":["Division of Pharmacy Practice, School of Pharmacy, University of North Carolina, Chapel Hill 27599","Division of Pharmacy Practice, School of Pharmacy, and Departments of University of North Carolina, Chapel Hill, North Carolina, U.S.A","Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacy Practice, School of Pharmacy, University of North Carolina, Chapel Hill 27599","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Division of Pharmacy Practice, School of Pharmacy, and Departments of University of North Carolina, Chapel Hill, North Carolina, U.S.A","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, U.S.A","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113770121","display_name":"Michael B. Tennison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Tennison","raw_affiliation_strings":["Neurology and University of North Carolina, Chapel Hill, North Carolina, U.S.A","Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology and University of North Carolina, Chapel Hill, North Carolina, U.S.A","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, U.S.A","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037746759","display_name":"Robert Greenwood","orcid":"https://orcid.org/0000-0002-6231-0253","observed_orcids":["https://orcid.org/0000-0002-6231-0253"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert S. Greenwood","raw_affiliation_strings":["Neurology and University of North Carolina, Chapel Hill, North Carolina, U.S.A","Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology and University of North Carolina, Chapel Hill, North Carolina, U.S.A","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, U.S.A","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019341812"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":1.4146,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.80462588,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"13","issue":"2","first_page":"166","last_page":"171"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.4934000074863434,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.4934000074863434,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.08810000121593475,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.05460000038146973,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.8679999709129333},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9990000128746033},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":1.0},{"id":"https://openalex.org/keywords/salivary-drug-concentration","display_name":"salivary drug concentration","score":0.9100000262260437},{"id":"https://openalex.org/keywords/intra-individual-variability","display_name":"within-person variability","score":0.9769999980926514},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9679999947547913},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C504460877","wikidata":"https://www.wikidata.org/wiki/Q155925","display_name":"Saliva","level":2,"score":0.9075706005096436},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.8909399509429932},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.86484694480896},{"id":"https://openalex.org/C2778060338","wikidata":"https://www.wikidata.org/wiki/Q30314615","display_name":"Fluorescence polarization immunoassay","level":2,"score":0.8217488527297974},{"id":"https://openalex.org/C2778793413","wikidata":"https://www.wikidata.org/wiki/Q407241","display_name":"Phenobarbital","level":2,"score":0.6688052415847778},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6104897260665894},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.532181978225708},{"id":"https://openalex.org/C89838059","wikidata":"https://www.wikidata.org/wiki/Q623738","display_name":"Coefficient of variation","level":2,"score":0.4985806941986084},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.398235946893692},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3540511131286621},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.3482874631881714},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3239039182662964},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13703614473342896},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010634","descriptor_name":"Phenobarbital","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D010634","descriptor_name":"Phenobarbital","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012463","descriptor_name":"Saliva","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D016231","descriptor_name":"Fluorescence Polarization Immunoassay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00007691-199103000-00013","doi":"https://doi.org/10.1097/00007691-199103000-00013","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-199103000-00013","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:2053125","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2053125","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1145164474","display_name":null,"funder_award_id":"RR-46","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2001446788","https://openalex.org/W2125160667","https://openalex.org/W2419149017","https://openalex.org/W2157481737","https://openalex.org/W1561073237","https://openalex.org/W2140871118","https://openalex.org/W1879610143","https://openalex.org/W2352260449","https://openalex.org/W2410424839","https://openalex.org/W2053962689"],"abstract_inverted_index":{"The":[0,94,155],"intraindividual":[1,95,204],"variability":[2,205],"of":[3,28,50,100,103,181,184,186,206,220,238],"salivary":[4],"carbamazepine":[5],"(CBZ),":[6],"phenobarbital":[7],"(PB),":[8],"and":[9,38,56,61,79,86,107,119,134,139,150,158,163,209],"phenytoin":[10],"(PHT)":[11],"concentrations":[12,63,211],"was":[13,192],"studied":[14],"in":[15,212],"six":[16],"healthy":[17],"male":[18],"volunteers.":[19],"During":[20],"three":[21],"consecutive":[22],"1-week":[23],"phases,":[24],"subjects":[25],"took":[26],"one":[27],"the":[29,46,104,179,187,203,216,235],"antiepileptic":[30],"drugs":[31],"(AED)":[32],"for":[33,83,110,124,140,161,173,190,197,234],"5":[34],"days.":[35],"Nine":[36],"saliva":[37,72,233],"nine":[39],"blood":[40],"samples":[41],"were":[42,64,88,112,127,143,165,171],"collected":[43],"simultaneously":[44],"over":[45],"last":[47],"4":[48],"days":[49],"each":[51,221],"phase.":[52],"Salivary,":[53],"unbound":[54,76],"serum,":[55],"total":[57],"serum":[58,74,77],"CBZ,":[59,84,207],"PB,":[60,85,208],"PHT":[62,87,141,164,210],"determined":[65],"by":[66],"fluorescence":[67],"polarization":[68],"immunoassay.":[69],"Individual":[70],"mean":[71,96,156],"(Cs)/total":[73],"(Ct),":[75],"(Cu)/Ct,":[78],"Cs/Cu":[80,108],"concentration":[81,218],"ratios":[82,109,160,219],"similar":[89],"to":[90],"those":[91],"reported":[92],"previously.":[93],"(+/-":[97],"SD)":[98],"coefficients":[99,183],"variation":[101,185],"(%)":[102],"Cs/Ct,":[105],"Cu/Ct,":[106],"CBZ":[111,162],"4.8":[113],"+/-":[114,117,121,129,132,136,145,148,152],"2.2%,":[115],"4.4":[116],"1.8%,":[118],"5.0":[120],"1.9%,":[122],"respectively;":[123,138],"PB":[125,174,191],"they":[126,142,170],"5.1":[128],"0.8%,":[130],"3.6":[131],"0.9%,":[133],"6.4":[135],"1.0%,":[137],"7.4":[144],"3.1%,":[146],"5.5":[147],"1.2%,":[149],"8.3":[151],"3.2%,":[153],"respectively.":[154],"Cs/Ct":[157,188],"Cu/Ct":[159],"not":[166,224],"significantly":[167],"different,":[168],"but":[169],"different":[172],"(p":[175],"=":[176],"0.01).":[177],"However,":[178],"range":[180],"individual":[182],"ratio":[189],"4.0-6.2%,":[193],"which":[194],"is":[195,223],"acceptable":[196],"clinical":[198],"monitoring.":[199],"We":[200],"conclude":[201],"that":[202,227],"saliva,":[213],"based":[214],"upon":[215],"saliva/serum":[217],"AED,":[222],"a":[225],"factor":[226],"should":[228],"dissuade":[229],"clinicians":[230],"from":[231],"using":[232],"therapeutic":[236],"monitoring":[237],"these":[239],"agents.":[240]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}